Pharmacist Contributions as Members of the Multidisciplinary ICU Team

被引:87
作者
Preslaski, Candice R. [1 ]
Lat, Ishaq [4 ]
MacLaren, Robert [2 ]
Poston, Jason [3 ]
机构
[1] Denver Hlth Med Ctr, Dept Inpatient Pharm, Denver, CO USA
[2] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Clin Pharm, Aurora, CO USA
[3] Univ Chicago, Pritzker Sch Med, Dept Med, Sect Pulm Crit Care Med, Chicago, IL 60637 USA
[4] Univ Chicago, Med Ctr, Dept Pharm, Chicago, IL 60637 USA
关键词
INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; ECONOMIC OUTCOMES; MEDICATION ERRORS; MANAGED AMINOGLYCOSIDE; CLINICAL PHARMACISTS; PATIENT HARM; SERVICES; SEDATION; IMPACT;
D O I
10.1378/chest.12-1615
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Critical care pharmacy services in the ICU have expanded from traditional dispensing responsibilities to being recognized as an essential component of multidisciplinary care for critically ill patients. Augmented by technology and resource utilization, this shift in roles has allowed pharmacists to provide valuable services in the form of assisting physicians and clinicians with pharmacotherapy decision-making, reducing medication errors, and improving medication safety systems to optimize patient outcomes. Documented improvements in the management of infections, anticoagulation therapy, sedation, and analgesia for patients receiving mechanical ventilation and in emergency response help to justify the need for clinical pharmacy services for critically ill patients. Contributions to quality improvement initiatives, scholarly and research activities, and the education and training of interdisciplinary personnel are also valued services offered by clinical pharmacists. Partnering with physician and nursing champions can garner support from hospital administrators for the addition of clinical pharmacy critical care services. The addition of a pharmacist to an interprofessional critical care team should be encouraged as health-care systems focus on improving the quality and efficiency of care delivered to improve patient outcomes.
引用
收藏
页码:1687 / 1695
页数:9
相关论文
共 53 条
[1]  
[Anonymous], 2010, Am J Health Syst Pharm, V67, P575, DOI 10.2146/sp100001
[2]  
[Anonymous], NAT PAT SAF GOALS EF
[3]   Prevention of intravenous drug incompatibilities in an intensive care unit [J].
Bertsche, Thilo ;
Mayer, Yvonne ;
Stahl, Rebekka ;
Hoppe-Tichy, Torsten ;
Encke, Jens ;
Haefeli, Walter Emil .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (19) :1834-1840
[4]   Clinical pharmacy services, pharmacy staffing, and hospital mortality rates [J].
Bond, C. A. ;
Raehl, Cynthia L. .
PHARMACOTHERAPY, 2007, 27 (04) :481-493
[5]   Clinical and economic outcomes of pharmacist-managed antimicrobial prophylaxis in surgical patients [J].
Bond, C. A. ;
Raehl, Cynthia L. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (18) :1935-1942
[6]   Clinical and economic outcomes of pharmacist-managed aminoglycoside or vancomycin therapy [J].
Bond, CA ;
Raehl, CL .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (15) :1596-1605
[7]   Pharmacist-provided anticoagulation management in United States hospitals: Death rates, length of stay, medicare charges, bleeding complications, and transfusions [J].
Bond, CA ;
Raehl, CL .
PHARMACOTHERAPY, 2004, 24 (08) :953-963
[8]   Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals [J].
Bond, CA ;
Raehl, CL ;
Franke, T .
PHARMACOTHERAPY, 2002, 22 (02) :134-147
[9]   Critical care delivery in the intensive care unit: Defining clinical roles and the best practice model [J].
Brilli, RJ ;
Spevetz, A ;
Branson, RD ;
Campbell, GM ;
Cohen, H ;
Dasta, JF ;
Harvey, MA ;
Kelley, MA ;
Kelly, KM ;
Rudis, MI ;
St Andre, AC ;
Stone, JR ;
Teres, D ;
Weled, BJ .
CRITICAL CARE MEDICINE, 2001, 29 (10) :2007-2019
[10]   Effect of pharmacists on medication errors in an emergency department [J].
Brown, Jamie N. ;
Barnes, Connie L. ;
Beasley, Beth ;
Cisneros, Robert ;
Pound, Melanie ;
Herring, Charles .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (04) :330-333